Celine Dion has stiff person syndrome (SPS), a rare neurological disorder that causes progressive muscle stiffness and painful spasms throughout the body. She publicly announced her diagnosis in December 2022, explaining that the condition had forced her to postpone and ultimately cancel her remaining tour dates. SPS affects an estimated 1 to 2 people per million, making it one of the rarest autoimmune conditions known.
What Stiff Person Syndrome Does to the Body
Stiff person syndrome is an autoimmune disorder in which the body’s immune system attacks a key enzyme involved in producing a brain chemical called GABA. GABA is the nervous system’s main “off switch,” the signal that tells muscles to relax and calms excessive nerve firing. When the immune system disrupts GABA production, the balance between muscle tension and muscle relaxation breaks down. The result is muscles that stay rigid when they should be loose and spasms that fire without warning.
The stiffness typically begins in the torso and legs, then spreads over time to the arms and face. Spasms can be triggered by surprisingly ordinary things: a loud noise, an unexpected touch, a sudden movement, or emotional stress. People with SPS sometimes become afraid to leave home because everyday sounds, like a car horn, can set off spasms severe enough to cause falls. Brain imaging studies confirm that GABA levels are significantly reduced in the areas of the brain that control movement, which explains why the muscles behave as though they’re permanently “on.”
How SPS Affects Dion’s Voice
For a singer, stiff person syndrome is uniquely devastating. The same muscle rigidity and spasms that lock up the limbs can also seize the muscles of the throat, including the vocal cords. Dion described the sensation in a 2024 interview, saying it feels like someone is strangling you, pushing your larynx and throat in directions it shouldn’t go. Her 2024 documentary, “I Am: Celine Dion,” showed that she could not sing as of filming because the spasms disrupted her vocal cords. Even warming up before singing, a critical part of vocal health she once sustained for hours, became impossible to maintain.
This is not the kind of vocal damage that rest or surgery can fix. Because SPS is a neurological and immune-driven problem, the spasms will continue as long as the underlying autoimmune process is active. Controlling the disease is the only path back to singing.
Diagnosis and Testing
SPS is notoriously difficult to diagnose because muscle stiffness and spasms have dozens of possible causes, and most doctors will never encounter a case. Formal diagnostic criteria, established in 2009, require a specific combination of findings: progressive stiffness in the trunk muscles that impairs walking, spasms triggered by noise or stress, electrical tests showing muscles firing continuously even at rest, high levels of a specific antibody called anti-GAD65 in the blood, and symptom improvement with certain medications.
The anti-GAD65 antibody is the hallmark blood marker. GAD65 is the enzyme the immune system mistakenly targets, and very high levels of antibodies against it in the bloodstream are a key diagnostic clue. Doctors also look for these antibodies in spinal fluid, which indicates the immune attack is happening directly in the central nervous system. Getting to this diagnosis often takes years because the early symptoms, occasional stiffness and unexplained muscle tension, can mimic anxiety disorders, fibromyalgia, or orthopedic problems.
Types of Stiff Person Syndrome
SPS exists on a spectrum. The classic form, which Dion has, involves widespread stiffness and spasms across the trunk and limbs. A more limited version called stiff limb syndrome confines the rigidity mainly to the legs. A more aggressive variant, progressive encephalomyelitis with rigidity and myoclonus (PERM), adds brain inflammation and jerking movements to the picture.
There is also a paraneoplastic variant linked to cancer, most commonly breast cancer. This form involves a different antibody (anti-amphiphysin rather than anti-GAD65) and requires screening for underlying tumors. Each variant has a somewhat different outlook and treatment approach, though all share the core problem of impaired GABA signaling and muscle hyperexcitability.
Treatment and What It Can Do
There is no cure for SPS, but treatments can reduce symptoms significantly. The first-line approach involves medications that boost GABA activity in the brain, helping restore some of the inhibitory signaling the disease disrupts. These drugs reduce muscle stiffness and lower the frequency of spasms, though the doses required can be high enough to cause heavy sedation.
For patients who don’t respond adequately, immunotherapy is the next step. A landmark study published in the New England Journal of Medicine found that intravenous immunoglobulin (IVIg), a treatment that modulates the immune system, effectively reduced stiffness and sensitivity to noise, touch, and stress. IVIg is well tolerated but expensive and typically needs to be repeated regularly. Plasma exchange, which filters antibodies from the blood, is another option. Some patients also receive immune-suppressing medications to slow the autoimmune attack over time.
Most patients improve with treatment, but the disease tends to fluctuate. Physical and emotional stress can trigger flare-ups even when someone is otherwise well managed. Early and aggressive treatment matters: starting therapy promptly can slow progression and reduce the risk of permanent disability.
Long-Term Outlook
The trajectory of SPS varies widely. Some patients stabilize with treatment and maintain a reasonable quality of life. Others experience gradual worsening despite therapy, developing permanent joint deformities, losing the ability to walk, and becoming significantly disabled. One long-term study found that only 19% of SPS patients were still able to work after four years of follow-up. Patients consistently report a sharply reduced quality of life due to both the physical limitations and the social isolation that comes with unpredictable, disabling spasms.
Prognosis depends on several factors: how early treatment begins, how well someone responds to immunotherapy, whether there’s an associated cancer, and the severity of symptoms at diagnosis. The disease is chronic and lifelong, but it is not typically fatal on its own.
Where Dion Stands Now
As of late 2025, Dion has not returned to performing. In her most recent public updates, she has appeared in good spirits, sharing messages of gratitude on social media and spending time with family. She was 57 at the time and looked healthy in video posts, though she has not announced any concert dates or a timeline for returning to the stage. Her 2024 documentary and interviews made clear that the road back to singing, if it’s possible, will be a long one. The spasms that affect her vocal cords represent one of the most challenging manifestations of a disease that, even in its more typical form, reshapes daily life entirely.